Q3 2019 Investor Presentation

Why invest? driving long-term shareholder value لحا Market Dynamics • Underpenetrated markets in sleep & COPD • Healthcare costs continue to increase · Focus on improving patient outcomes • Value-based technology solutions Growth & Innovation Global leader in connected health for sleep and respiratory care • Long-term growth opportunities 5,500+ patents and designs1 • 7-8% of revenue 2 invested in R&D Financial Results • Historical revenue and • • profit growth Recurring revenue Operating excellence program Strong track record of disciplined capital deployment 1. Pending and issued patents and designs as of 3/31/2019 ©2019 ResMed I Q3 2019 Investor Presentation | 44 ResMed

View entire presentation